Perrigo (PRGO) to Release Quarterly Earnings on Thursday

Perrigo (NYSE:PRGO) is anticipated to release its earnings data after the market closes on Thursday, February 27th. Analysts expect Perrigo to post earnings of $0.92 per share and revenue of $1.20 billion for the quarter.

Perrigo Stock Down 0.1 %

PRGO stock opened at $25.23 on Wednesday. The stock’s fifty day simple moving average is $24.92 and its two-hundred day simple moving average is $26.20. The company has a current ratio of 2.56, a quick ratio of 1.77 and a debt-to-equity ratio of 0.94. Perrigo has a 1-year low of $23.14 and a 1-year high of $33.46. The stock has a market cap of $3.44 billion, a P/E ratio of -21.56 and a beta of 0.54.

Perrigo Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 25th. Shareholders of record on Friday, March 7th will be given a $0.29 dividend. The ex-dividend date of this dividend is Friday, March 7th. This represents a $1.16 annualized dividend and a yield of 4.60%. This is a boost from Perrigo’s previous quarterly dividend of $0.28. Perrigo’s payout ratio is currently -99.15%.

Insider Activity at Perrigo

In other Perrigo news, Director Jeffrey B. Kindler sold 17,598 shares of the company’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $28.27, for a total transaction of $497,495.46. Following the completion of the transaction, the director now owns 5,409 shares of the company’s stock, valued at $152,912.43. This represents a 76.49 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.40% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several analysts have issued reports on PRGO shares. Argus lowered Perrigo from a “buy” rating to a “hold” rating in a research note on Tuesday, January 14th. Piper Sandler lowered Perrigo from an “overweight” rating to a “neutral” rating and lowered their target price for the company from $34.00 to $27.00 in a research note on Monday, January 6th. Finally, StockNews.com lowered Perrigo from a “buy” rating to a “hold” rating in a research note on Wednesday, February 19th. Four research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, Perrigo presently has an average rating of “Hold” and an average target price of $35.00.

About Perrigo

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.